Biography and Research Information
OverviewAI-generated summary
Eniya Beemarajan's research focuses on neurological disorders, particularly dystonia, in children. Her work investigates the genetic underpinnings of these conditions, with a recent publication examining a case of KMT2B-related dystonia in a young child presenting with worsening gait abnormalities. Beemarajan also contributes to the understanding of potential adverse effects associated with novel medical treatments, as indicated by her publication on acute liver injury following gene therapy. Her scholarship metrics include an h-index of 2, with 2 total publications and 10 total citations. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Aravindhan Veerapandiyan and Megan W. Butler, with whom she has co-authored multiple publications.
Metrics
- h-index: 2
- Publications: 2
- Citations: 10
Selected Publications
-
Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin (2024)
Collaboration Network
Top Collaborators
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Child Neurology: <i>KMT2B</i> -Related Dystonia in a Young Child With Worsening Gait Abnormality
- Child Neurology: <i>KMT2B</i> -Related Dystonia in a Young Child With Worsening Gait Abnormality
- Child Neurology: <i>KMT2B</i> -Related Dystonia in a Young Child With Worsening Gait Abnormality
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
Similar Researchers
Based on overlapping research topics